Zobrazeno 1 - 10
of 22
pro vyhledávání: ''
Autor:
Bodmer, D.1, Ligtenberg, M. J. L.1,2, van der Hout, A. H.3, Gloudemans, S.1, Ansink, K.1, Oosterwijk, J. C.3, Hoogerbrugge, N.1 N.Hoogerbrugge@antrg.umcn.nl
Publikováno v:
British Journal of Cancer. 9/18/2006, Vol. 95 Issue 6, p757-762. 6p. 2 Charts, 1 Graph.
Autor:
Jønson, Lars, Ahlborn, Lise, Steffensen, Ane, Djursby, Malene, Ejlertsen, Bent, Timshel, Susanne, Nielsen, Finn, Gerdes, Anne-Marie, Hansen, Thomas
Publikováno v:
Breast Cancer Research & Treatment; Jan2016, Vol. 155 Issue 2, p215-222, 8p
Autor:
Hansen, Thomas, Jønson, Lars, Steffensen, Ane, Andersen, Mette, Kjaergaard, Susanne, Gerdes, Anne-Marie, Ejlertsen, Bent, Nielsen, Finn
Publikováno v:
Familial Cancer; Jun2011, Vol. 10 Issue 2, p207-212, 6p
Autor:
Steffensen, Ane, Jønson, Lars, Ejlertsen, Bent, Gerdes, Anne-Marie, Nielsen, Finn, Hansen, Thomas
Publikováno v:
Familial Cancer; Sep2010, Vol. 9 Issue 3, p283-287, 5p
Autor:
Fedorova, O. E., Lyubchenko, L. N., Payanidi, Yu. G., Kazubskaya, T. P., Amosenko, F. A., Garkavtseva, R. F., Zasedatelev, A. S., Nasedkina, T. V.
Publikováno v:
Molecular Biology; Jan2007, Vol. 41 Issue 1, p32-36, 5p, 1 Diagram, 2 Charts
Autor:
Pietschmann, Andrea, Mehdipour, Parvin, Atri, Morteza, Hofmann, Wera, Hosseini-Asl, S. Said, Scherneck, Siegfried, Mundlos, Stefan, Peters, Hartmut
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Aug2005, Vol. 131 Issue 8, p552-558, 7p
Autor:
Beverley S. Speight, Marc Tischkowitz
Publikováno v:
Journal of Genetic Counseling
Germline mutations in BRCA1/BRCA2 significantly increase the risk of breast and ovarian cancer in women. This case report describes a BRCA1 germline mutation identified in a woman with stage IV epithelial ovarian cancer and the provision of genetic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b90b871eb5876d60696048fbb8078c6
https://www.repository.cam.ac.uk/handle/1810/267347
https://www.repository.cam.ac.uk/handle/1810/267347
Publikováno v:
British Journal of Cancer
This study sought to examine changes in psychological distress following cancer genetic counselling. Women attending a family cancer clinic completed questionnaires before their appointment and at 2 weeks, 6 months and 12 months after their appointme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e408bb98c755ca3e0a4394f3ca58f04
https://openaccess.sgul.ac.uk/id/eprint/1639/1/86-6600030a.pdf
https://openaccess.sgul.ac.uk/id/eprint/1639/1/86-6600030a.pdf
Autor:
Jan Steffen, Michalina Dabrowska, Aneta Balabas, Magdalena Piatkowska, Dorota Nowakowska, Izabela Brozek, Anna Niwińska, Magdalena Ratajska, Jadwiga Rachtan, Janusz Limon, Anna Kluska
Publikováno v:
Familial Cancer
It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis
Autor:
Riikka Nurminen, Johanna Schleutker, Heli Nevanlinna, Liisa M. Pelttari, Lauri A. Aaltonen, Alexandra E. Gylfe
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 552 (2012)
BMC Cancer
BMC Cancer
Background Rare, heterozygous germline mutations in the RAD51C gene have been found in breast and ovarian cancer families. In the Finnish population, we have identified two founder mutations in RAD51C that increase the risk of ovarian cancer but not